Skip to main content
Equibles

WELLINGTON MANAGEMENT GROUP LLP

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 902219 Boston, MA
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$662,792
+$197,937 QoQ
Shares Held
180,598
+19.3% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 344 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority Sole 0% Shared 94% None 6%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. RXRX ranks #180 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,247,658 $1,613,209,155
2 ARGX
Argenx SE
 930,548 $863,334,513
3 REGN
Regeneron Pharmaceuticals, Inc.
 1,270,087 $791,950,042
4 RVMD
Revolution Medicines, Inc.
 3,843,415 $719,794,757
5 ALNY
Alnylam Pharmaceuticals, Inc.
 2,110,407 $635,295,816
6 IONS
Ionis Pharmaceuticals Inc
 7,651,415 $606,680,693
7 CYTK
Cytokinetics Inc
 6,931,770 $590,517,483
8 MDGL
Madrigal Pharmaceuticals, Inc.
 825,714 $443,367,129

All Filings in RXRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $662,792 180,598
2026-03-31 $464,855 151,419
2025-12-31 $624,197 152,616
2025-09-30 $747,990 153,277
2025-06-30 $480,607 94,982
2025-03-31 $568,546 107,476
2024-12-31 $777,026 114,945
2024-09-30 $692,066 105,018